Background Successful reversal of abrupt vessel closure without result
ant major ischemic complications (death, Q-wave myocardial infarction,
or coronary artery bypass graft surgery) is achieved in nearly half o
f all cases of abrupt vessel closure. The long-term outcome of these p
atients has not been previously addressed, and it is not clear whether
they have a different prognosis than that of patients who have a succ
essful procedure not associated with transient vessel closure. Methods
and Results We examined 4863 consecutive patients who underwent succe
ssful percutaneous transluminal coronary angioplasty (PTCA) or directi
onal coronary atherectomy (DCA). Eighty-eight patients had an uncompli
cated, successfully reversed transient in-laboratory vessel closure (g
roup 2) and were compared with 4775 patients who had a successful proc
edure not associated with transient in-laboratory closure (group I). C
linical follow-up was available in 4839 patients (99.5%), with a mean
duration of 41+/-23 months (range, 1 to 104 months). Survival analysis
showed that successfully treated, uncomplicated transient vessel clos
ure per se does not have an adverse effect on long-term prognosis (dea
th, myocardial infarction, or coronary interventions). However, when t
he procedure (PTCA or DCA) was associated with an increase in creatine
kinase-MB (CK-MB), there was a significant adverse effect on long-ter
m outcome. By multivariate logistic regression, an increase in postpro
cedure CK-MB was the most significant correlate for cardiac death (ris
k ratio, 1.25; P<.0001). An increase in CK-MB was also the most import
ant correlate for major ischemic complications (death, infarction, or
coronary interventions) on follow-up (risk ratio, 1.08; P=.0005). Conc
lusions Transient, uncomplicated in-laboratory vessel closure per se d
oes not have an adverse long-term effect. However, a concomitant eleva
tion of postprocedure cardiac enzymes has an important and significant
adverse effect on long-term outcome. This study suggests that peripro
cedural creatine kinase isoenzyme determination in patients experienci
ng in-laboratory coronary closure has important prognostic implication
s.